Asymptomatic Osteomalacia in Pregnancy
DOI:
https://doi.org/10.25130/Keywords:
ALP, PTH, Osteomalacia, Pregnancy, HSAPAbstract
Background:
Alkaline phosphatase (ALP) is important enzyme in diagnosis many diseases like osteomalacia. It presents in defect isoenzyme including bone, liver, and placental ALP.
Aims of this study:
Assess the efficacy of the bone ALP enzyme and intact parathyroid hormone (iPTH) to detect the possible presence of osteomalacia in pregnant women due to the vitamin D deficiency.
Objective:
Evaluate the nutritional state of pregnant women that will affect the good health of her bone and preparing her for lactation stage.
Methods:
Blood samples were collected from 87 normal fasting pregnant women then subdivided them into three subgroups according to their period of gestation. ALP and its isoenzyme were determined calorimetrically after separation of them by thermal stability method, and the level of parathyroid hormone was measured for 36 of them from different subgroups by the ELISA technique. Statistical test used as t-test (student test) and leaner regression .
Results:
There was a difference in the activity rates of the heat labile enzyme (HLAP), which is mostly related to the bones when compared between groups, and showed that there is a positive relationship between the activity of this enzyme with the activity of the placental isoenzyme and with the gestational age. PTH showed an increasing in its level and a direct proportion with placental isoenzyme.
Conclusion and recommendation:
Increased bone (ALP) isoenzyme, and elevated PTH could be a marker of osteomalacia in pregnancy, accordingly, we recommend a measurement of parathyroid hormone and placental, bone ALP in pregnant women to ensure the health of the placenta and bone.